Introducing Ro’s GLP-1 Supply Tracker: a free, open-access tool to help you find which GLP-1s are available (and where) and which aren’t. Sign-up for real-time, localized supply alerts, see which drugs are in shortage, and share your shortage experiences.

RT @ZReitano: Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-ap….

Curious if your insurance covers GLP-1s? Ro’s Insurance Coverage Checker has helped hundreds of thousands. Now, we're revealing key insights in our new report on GLP-1 access. Read the full report:

RT @flahertyiv: Some *BIG* news from the team @ro today — we're thrilled to announce a new partnership with the one and only Charles Barkle….

RT @CNBCFastMoney: A new deal between @Ro and $NVO allows patients to get its flagship weight loss drug Wegovy for as low as $499 per month….

RT @ZReitano: Today, @ro is announcing a collaboration with @novonordisk — starting with an integration with NovoCare® Pharmacy. Fighting….

RT @ZReitano: $LLY lowering the price of the vials! $349 for 2.5 and $499 for higher doses on monthly orders. Big win for patients!. Also…….

Ro is working with @EliLillyandCo! Through a first-of-its-kind integration with LillyDirect, Zepbound single-dose vials are now available through Ro – offering a seamless obesity care experience bringing together telehealth, lab, and pharmacy services.

RT @ZReitano: 1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. .

Patients come to Ro for the care they need to live happier, more fulfilled lives. Today, we’re sharing research highlighting the many ways accessing obesity care through Ro can change lives:

Tune in at 2:50PM ET to catch Ro CEO, @ZReitano chat with @Axios' @danprimack about the impact of GLP-1s on the healthcare system and beyond at #AxiosBFD!

RT @axios: @WashSpirit @sarafischer Catch @Ro CEO @ZReitano at in conversation with @danprimack at #AxiosBFD in New York. Tune in tomorrow….

We appreciate the Senate HELP Committee's focus on expanding access to GLP-1 medications, such as Ozempic and Wegovy, for more patients. Beyond those paying cash or without insurance, our data shows that even patients with coverage can face high costs.

Ro has conducted benefits verifications for patients nationwide. Our insights reveal that there is still so much more to be done to help patients access high-quality obesity care – from increasing ins. coverage to removing roadblocks to care. #ObesityCareNOW

How can people maintain muscle while on GLP-1s? Our team and advisors, @BevTchangMD & Dr. David Allison, delve into the relationship between weight loss and muscle mass + strength, plus share insights on maintaining both with lifestyle interventions.

Thanks for standing tall, @ShannonSharpe. You're not the only one getting it in - we created Ro Sparks to help millions of guys do the act. We got you 💪.

At Ro, we are rooting for the GLP-1 shortages to end ASAP. Since introducing our GLP-1 Supply Tracker three months ago though, we've received over 60k drug shortage reports. Dive into our latest blog to learn what this data reveals about the shortages:

RT @CNBCFastMoney: Checking GLP-1 drug insurance coverage just got a little easier, thanks to a new tool from @ro. CEO @ZReitano explains….

RT @CNBC: Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Introducing the GLP-1 Insurance Coverage Checker – a free tool that empowers anyone to easily check if their insurance covers GLP-1s medications and understand their potential OOP costs at the very beginning of their journey.